Altre lingue DeepMind Platform Co., Ltd.

Azioni

A223310

KR7223310004

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 28/06/2024			Variaz. 5gg	Var. 1 gen.
3.055 ^KRW	+7,19%		+12,32%	+82,28%

20/06	Il Regno Unito occupa il primo posto in Europa per le startup GenAI, secondo Accel	RE
2022	Gemtech & Company Co., Ltd. ha annullato l'acquisizione della partecipazione del 3,23% in Commerce miner Co., Ltd. (KOSDAQ:A223310). (KOSDAQ:A223310) da CODI-M Co., Ltd. (KOSDAQ:A224060).	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

UK takes top spot in Europe for GenAI startups, Accel says	20/06
DeepMind Platform Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Atas Partners Inc., Jang San Co.,Ltd.	19/04
DeepMind Platform Co., Ltd. announced that it has received KRW 8.999999063 billion in funding from Metaplex Co., Ltd.	15/04
DeepMind Platform Co., Ltd. announced that it expects to receive KRW 9.999999804 billion in funding from Metaplex Co., Ltd.	20/03
Commerce miner Co., Ltd. announced that it has received KRW 999.999885 million in funding	28/11/22
Commerce miner Co., Ltd. announced that it expects to receive KRW 999.999885 million in funding	18/11/22
Gemtech & Company Co., Ltd. cancelled the acquisition of 3.23% stake in Commerce miner Co., Ltd. from CODI-M Co., Ltd..	28/10/22
Commerce miner Co., Ltd. announced that it has received KRW 4.99999801 billion in funding	02/08/22
Commerce miner Co., Ltd. announced that it expects to receive KRW 4.99999801 billion in funding	18/07/22
Commerce miner Co., Ltd. acquired Remarkable Labs Co,.Ltd. from Lee Eun-seok.	01/07/22
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	20/07/21
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	12/07/21
Hanjung Construction Co.,Ltd. agreed to acquire 27.5% stake in PSMC CO., Ltd from Kyung Nam Pharm Health Care Co., Ltd. for KRW 9.3 billion.	04/11/20
ESV Inc. announced that it has received KRW 4.999999932 billion in funding from KyungNam Biopharma CO.,LTD.	01/06/20
ESV Inc. announced that it expects to receive KRW 4.999999932 billion in funding	27/02/20
ESV Inc. announced that it has received KRW 3 billion in funding	11/04/19
ESV Inc. announced that it has received KRW 3 billion in funding	13/02/19
ESV Inc. announced that it has received KRW 3 billion in funding	13/02/19
ESV Inc. announced that it has received KRW 30.0000006 billion in funding	08/10/18
ESV Inc. announced that it has received KRW 2.999999849 billion in funding from Celrun Co., Ltd., ESA Co., Ltd.	08/10/18

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue DeepMind Platform Co., Ltd.

Azioni

A223310

KR7223310004

Altre lingue

Filtri